Clinical trial

Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)

NCT00839176

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE2

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2013-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorder (MDD)unresolved

Interventions

RX-10100DRUG

Sponsors & collaborators

Rexahn Pharmaceuticals, Inc.lead sponsor

Mapped research locations

AtlantaGeorgia, United States1 DenverColorado, United States1 RockvilleMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00839176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.